1
|
Rohila Y, Sebastian S, Ansari A, Kumar D, Mishra DK, Gupta MK. A Comprehensive Review of the Diverse Spectrum Activity of 1,2,3-Triazole-linked Isatin Hybrids. Chem Biodivers 2024; 21:e202301612. [PMID: 38332679 DOI: 10.1002/cbdv.202301612] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2023] [Revised: 01/24/2024] [Accepted: 02/08/2024] [Indexed: 02/10/2024]
Abstract
Heterocyclic compounds containing 1,2,3-triazole and isatin as core structures have emerged as promising drug candidates due to their diverse biological activities such as anti-cancer, antifungal, antimicrobial, antitumor, anti-epileptic, antiviral, and more. The presence of 1,2,3-triazoles and isatin heterocycles in these hybrids, both individually known for their medicinal significance, has increasingly piqued the interest of drug discovery researchers, as they seek to delve deeper into their extensive pharmacological potential for enhancing therapeutic efficacy. Moreover, these hybrid compounds are synthetically accessible using readily available materials. Therefore, there is a pressing need to provide a comprehensive overview of the existing knowledge in this field, offering valuable insights to readers and paving the way for the discovery of novel 1,2,3-triazole-linked isatin hybrids with therapeutic potential.
Collapse
Affiliation(s)
- Yajat Rohila
- Department of Chemistry, School of Basic Sciences, Department of Chemistry, Central University of Haryana. Mahendergarh-123031, Haryana, India
| | - Sharol Sebastian
- Department of Chemistry, School of Basic Sciences, Department of Chemistry, Central University of Haryana. Mahendergarh-123031, Haryana, India
| | - Azaj Ansari
- Department of Chemistry, School of Basic Sciences, Department of Chemistry, Central University of Haryana. Mahendergarh-123031, Haryana, India
| | - Deepak Kumar
- Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, Solan, 173229, Himachal Pradesh, India
| | - D K Mishra
- Department of Chemistry, Shri Ramswaroop Memorial College of Engineering & Management, Lucknow, 226028, Uttar Pradesh, India
| | - Manoj K Gupta
- Department of Chemistry, School of Basic Sciences, Department of Chemistry, Central University of Haryana. Mahendergarh-123031, Haryana, India
| |
Collapse
|
2
|
Varpe BD, Kulkarni AA, Jadhav SB, Mali AS, Jadhav SY. Isatin Hybrids and Their Pharmacological Investigations. Mini Rev Med Chem 2021; 21:1182-1225. [PMID: 33302835 DOI: 10.2174/1389557520999201209213029] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2020] [Revised: 09/01/2020] [Accepted: 10/16/2020] [Indexed: 11/22/2022]
Abstract
Hybridization is an important strategy to design molecules that can be effectively used to treat fatal diseases known to mankind. Molecular hybrids and their pharmacological investigations aided in discovering several potent isatin (Indole 2, 3 dione) derivatives with anti-HIV, antimalarial, antitubercular, antibacterial, and anticancer activities. Indole-2,3-dione and their derivatives have diverse pharmacological properties and have a prominent role in the discovery of new drugs. To understand the various approaches for designing new molecules based on isatin nucleus analysis of various pharmacophore hybrids, spacers/linkers between pharmacophores and isatin for hybridization and their biological activities are important. This review discusses the progress in developing isatin hybrids as biologically effective agents and their crucial aspects of design and structure-activity relationships.
Collapse
Affiliation(s)
- Bhushan D Varpe
- Department of Pharmaceutical Chemistry, DKSS's Institute of Pharmaceutical Science and Research, Swami Chincholi, Dist-Pune, 413130 Maharashtra, India
| | - Amol A Kulkarni
- Department of Pharmaceutical Chemistry, DKSS's Institute of Pharmaceutical Science and Research, Swami Chincholi, Dist-Pune, 413130 Maharashtra, India
| | - Shailaja B Jadhav
- PES's Modern College of Pharmacy, Nigdi, Pune, 411044, Maharashtra, India
| | - Anil S Mali
- Department of Pharmaceutical Chemistry, DKSS's Institute of Pharmaceutical Science and Research, Swami Chincholi, Dist-Pune, 413130 Maharashtra, India
| | - Shravan Y Jadhav
- Department of Chemistry, DBF Dayanand College of Arts & Science, Solapur 413002, Maharashtra, India
| |
Collapse
|
3
|
Liang T, Sun X, Li W, Hou G, Gao F. 1,2,3-Triazole-Containing Compounds as Anti-Lung Cancer Agents: Current Developments, Mechanisms of Action, and Structure-Activity Relationship. Front Pharmacol 2021; 12:661173. [PMID: 34177578 PMCID: PMC8226129 DOI: 10.3389/fphar.2021.661173] [Citation(s) in RCA: 41] [Impact Index Per Article: 13.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2021] [Accepted: 05/19/2021] [Indexed: 12/19/2022] Open
Abstract
Lung cancer is the most common malignancy and leads to around one-quarter of all cancer deaths. Great advances have been achieved in the treatment of lung cancer with novel anticancer agents and improved technology. However, morbidity and mortality rates remain extremely high, calling for an urgent need to develop novel anti-lung cancer agents. 1,2,3-Triazole could be readily interact with diverse enzymes and receptors in organisms through weak interaction. 1,2,3-Triazole can not only be acted as a linker to tether different pharmacophores but also serve as a pharmacophore. This review aims to summarize the recent advances in 1,2,3-triazole-containing compounds with anti-lung cancer potential, and their structure-activity relationship (SAR) together with mechanisms of action is also discussed to pave the way for the further rational development of novel anti-lung cancer candidates.
Collapse
Affiliation(s)
- Ting Liang
- Key Laboratory for Experimental Teratology of the Ministry of Education and Biomedical Isotope Research Center, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Xiangyang Sun
- Department of Interventional Radiology, Qilu Hospital of Shandong University, Jinan, China
| | - Wenhong Li
- Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
| | - Guihua Hou
- Key Laboratory for Experimental Teratology of the Ministry of Education and Biomedical Isotope Research Center, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Feng Gao
- Key Laboratory for Experimental Teratology of the Ministry of Education and Biomedical Isotope Research Center, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China
| |
Collapse
|
4
|
Guo H, Diao QP. The Anti-Breast Cancer Potential of Bis-Isatin Scaffolds. Curr Top Med Chem 2021; 20:1499-1503. [PMID: 32156238 DOI: 10.2174/1568026620666200310124416] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2020] [Revised: 02/06/2020] [Accepted: 02/07/2020] [Indexed: 02/07/2023]
Abstract
AIM To develop novel anti-breast cancer agents and discuss the structure-activity relationship of bis-isatin scaffolds. BACKGROUND Breast cancer is the most common invasive cancer and the second leading cause of cancer death in women after lung cancer. Bis-isatin scaffolds possess potential anti-breast cancer activity, and some of them such as Indirubin could induce cancer cells apoptosis via multiply mechanisms. OBJECTIVE The primary objective of this study was to evaluate the potential of bis-isatin scaffolds with alkyl/ether linkers between the two isatin moieties against different human breast cancer cell lines including MCF-7, AU565, MDA-MB-231, MDA-MB-435 and MDA-MB-468 cells. METHODS The synthesized bis-isatin scaffolds with alkyl/ether linker between the two isatin moieties were evaluated for their in vitro activity against MCF-7, AU565, MDA-MB-231, MDA-MB-435, and MDA-MB-468 human breast cancer cell lines by MTT assay. RESULTS All the synthesized compounds (IC50: 38.3-197.6 µM) possess considerable activity against MCF-7, AU565, MDA-MB-231, MDA-MB-435, and MDA-MB-468 human breast cancer cell lines, and the most potent compound 4e (IC50: 38.3-63.5 µM) was no inferior to Cisplatin (IC50: 20.1-38.6 μM) against the five tested human breast cancer cell lines. CONCLUSION All the synthesized bis-isatin scaffolds were active against a panel of breast cancer cell lines, highlighting the significance of exploring the bis-isatin scaffolds to fight against breast cancers. The enriched structure-activity relationship may set up the direction for the rational design and development of novel bis-isatin scaffolds with higher efficiency.
Collapse
Affiliation(s)
- Hua Guo
- School of Chemistry and Life Science, Anshan Normal University, Liaoning, China
| | - Quan-Ping Diao
- School of Chemistry and Life Science, Anshan Normal University, Liaoning, China
| |
Collapse
|
5
|
Jia Y, Wen X, Gong Y, Wang X. Current scenario of indole derivatives with potential anti-drug-resistant cancer activity. Eur J Med Chem 2020; 200:112359. [PMID: 32531682 DOI: 10.1016/j.ejmech.2020.112359] [Citation(s) in RCA: 55] [Impact Index Per Article: 13.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2020] [Revised: 04/09/2020] [Accepted: 04/16/2020] [Indexed: 02/07/2023]
Abstract
Cancer chemotherapy is frequently hampered by drug resistance, so the resistance to anticancer agents represents one of the major obstacles for the effective cancer treatment. Indole derivatives have the potential to act on diverse targets in cancer cells and exhibit promising activity against drug-resistant cancers. Moreover, some indole-containing compounds such as Semaxanib, Sunitinib, Vinorelbine, and Vinblastine have already been applied in clinics for various kinds of cancer even drug-resistant cancer therapy. Thus, indole derivatives are one of significant resources for the development of novel anti-drug-resistant cancer agents. This review focuses on the recent development of indole derivatives with potential therapeutic application for drug-resistant cancers, and the mechanisms of action, the critical aspects of design as well as structure-activity relationships, covering articles published from 2010 to 2020.
Collapse
Affiliation(s)
- Yanshu Jia
- Chongqing Institute of Engineering, Chongqing, 400056, China
| | - Xiaoyue Wen
- The Institute of Infection and Inflammation, China Three Gorges University, Yichang, Hubei, 443000, China
| | - Yufeng Gong
- The Second Affiliated Hospital of Mudanjiang Medical University, Mudanjiang, 157000, China
| | - Xuefeng Wang
- Department of Surgery, Zhuji Affiliated Hospital of Shaoxing University, Zhejiang Province, 311800, China.
| |
Collapse
|
6
|
Zhang Y, Du H, Liu H, He Q, Xu Z. Isatin dimers and their biological activities. Arch Pharm (Weinheim) 2020; 353:e1900299. [DOI: 10.1002/ardp.201900299] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2019] [Revised: 12/20/2019] [Accepted: 12/28/2019] [Indexed: 12/12/2022]
Affiliation(s)
- Ya‐Zhou Zhang
- Teaching and Research Office of Analytical Chemistry, School of Pharmaceutical SciencesGuizhou University of Traditional Chinese Medicine Guizhou China
| | - Hong‐Zhi Du
- Teaching and Research Office of Analytical Chemistry, School of Pharmaceutical SciencesGuizhou University of Traditional Chinese Medicine Guizhou China
| | - Hai‐Lin Liu
- Teaching and Research Office of Analytical Chemistry, School of Pharmaceutical SciencesGuizhou University of Traditional Chinese Medicine Guizhou China
| | - Qian‐Song He
- Teaching and Research Office of Analytical Chemistry, School of Pharmaceutical SciencesGuizhou University of Traditional Chinese Medicine Guizhou China
| | - Zhi Xu
- Teaching and Research Office of Analytical Chemistry, School of Pharmaceutical SciencesGuizhou University of Traditional Chinese Medicine Guizhou China
| |
Collapse
|
7
|
Ding Z, Zhou M, Zeng C. Recent advances in isatin hybrids as potential anticancer agents. Arch Pharm (Weinheim) 2020; 353:e1900367. [PMID: 31960987 DOI: 10.1002/ardp.201900367] [Citation(s) in RCA: 65] [Impact Index Per Article: 16.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2019] [Revised: 12/27/2019] [Accepted: 12/28/2019] [Indexed: 11/06/2022]
Abstract
The isatin framework is a useful template for the development of novel anticancer agents. This is exemplified by the fact that several isatin-based anticancer agents, such as semaxanib, sunitinib, nintedanib, and hesperadin, are already in use or under clinical trials for the treatment of diverse kinds of cancers. Isatin-based hybrids could be obtained by incorporating other anticancer pharmacophores into the isatin skeleton and they have the potential to overcome drug resistance with reduced side effects. Thus, isatin-based hybrids may provide attractive scaffolds for the development of novel anticancer agents. This review covers the recent advances of isatin-based hybrids with anticancer activity, covering articles published between 2001 and 2019. The anticancer activities of these molecules and the structure-activity relationships are also discussed. The purpose of this review article is to set up the direction for the design and development of isatin-based hybrids with high efficacy and low toxicity.
Collapse
Affiliation(s)
- Zhen Ding
- Department of Pharmacy, Bozhou People's Hospital, Bozhou, China
| | - Minfeng Zhou
- Department of General Practice, Zhuji Affiliated Hospital of Shaoxing University, Shaoxing, China
| | - Cheng Zeng
- Department of Pharmacy, Bozhou People's Hospital, Bozhou, China
| |
Collapse
|
8
|
Liu B, Wang G, Peng Y, Tang X, Hu G. Design, synthesis, and in vitro antimycobacterial activities of butylene tethered 7‐fluoroisatin‐isatin scaffolds. J Heterocycl Chem 2019. [DOI: 10.1002/jhet.3696] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Affiliation(s)
- Bi Liu
- School of Nuclear Technology and Chemistry and BiologyHubei University of Science and Technology Xianning People's Republic of China
| | - Gang‐Qiang Wang
- School of Nuclear Technology and Chemistry and BiologyHubei University of Science and Technology Xianning People's Republic of China
| | - Yan‐Hong Peng
- School of Nuclear Technology and Chemistry and BiologyHubei University of Science and Technology Xianning People's Republic of China
| | - Xiu‐Qin Tang
- School of Nuclear Technology and Chemistry and BiologyHubei University of Science and Technology Xianning People's Republic of China
| | - Guo‐Wen Hu
- School of Nuclear Technology and Chemistry and BiologyHubei University of Science and Technology Xianning People's Republic of China
| |
Collapse
|
9
|
Xu Z, Zhao SJ, Liu Y. 1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships. Eur J Med Chem 2019; 183:111700. [PMID: 31546197 DOI: 10.1016/j.ejmech.2019.111700] [Citation(s) in RCA: 269] [Impact Index Per Article: 53.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2019] [Revised: 09/08/2019] [Accepted: 09/12/2019] [Indexed: 12/15/2022]
Abstract
Anticancer agents are critical for the cancer treatment, but side effects and the drug resistance associated with the currently used anticancer agents create an urgent need to explore novel drugs with low side effects and high efficacy. 1,2,3-Triazole is privileged building block in the discovery of new anticancer agents, and some of its derivatives have already been applied in clinics or under clinical trials for fighting against cancers. Hybrid molecules occupy an important position in cancer control, and hybridization of 1,2,3-triazole framework with other anticancer pharmacophores may provide valuable therapeutic intervention for the treatment of cancer, especially drug-resistant cancer. This review emphasizes the recent advances in 1,2,3-triazole-containing hybrids with anticancer potential, covering articles published between 2015 and 2019, and the structure-activity relationships, together with mechanisms of action are also discussed.
Collapse
Affiliation(s)
- Zhi Xu
- Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, PR China.
| | - Shi-Jia Zhao
- Wuhan University of Science and Technology, Wuhan, PR China
| | - Yi Liu
- Wuhan University of Science and Technology, Wuhan, PR China.
| |
Collapse
|
10
|
Cheng R, Yan X, Xu Z. Isatin‐1,2,3‐triazole‐isatin Scaffolds and Their Antibacterial Activity. J Heterocycl Chem 2019. [DOI: 10.1002/jhet.3689] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Affiliation(s)
- Ruijing Cheng
- School of mathematics and physicsQiongtai Normal University Haikou 571127 People's Republic of China
| | - Xinjia Yan
- College of PharmacyHarbin University of Commerce Harbin 150076 People's Republic of China
| | - Zhi Xu
- College of Chemistry and Pharmaceutical EngineeringHuanghuai University Zhumadian 463000 People's Republic of China
| |
Collapse
|
11
|
Zhang L, Zhao S, Xu Z, Liu Y. Investigation of the Anti‐human Immunodeficiency Virus Activity of Heteronuclear Bis‐isatin Scaffolds Tethered through Propyl and Butyl. J Heterocycl Chem 2019. [DOI: 10.1002/jhet.3691] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Longfei Zhang
- Department of ChemistryTsinghua University Beijing 100084 People's Republic of China
| | - Shijia Zhao
- College of Chemistry and Chemical EngineeringWuhan University of Science and Technology Wuhan 430081 People's Republic of China
| | - Zhi Xu
- College of Chemistry and Pharmaceutical EngineeringHuanghuai University Zhumadian 463000 People's Republic of China
| | - Yi Liu
- College of Chemistry and Chemical EngineeringWuhan University of Science and Technology Wuhan 430081 People's Republic of China
| |
Collapse
|